EUVIMEDEUVIMED entdecken
Crossref

Prostatic Enlargement in Acromegaly Despite Preserved Lower Urinary Tract Function: A Cross‐Sectional Comparative Study

Serafettin Kaymak iD, Halil Lutfi Canat iD, Aylin Coskun iD, Muhammed Zeki Cicek, Hamit Yucel Barut, Mutlu Niyazoglu, Esra Hatipoglu iD

The Prostate · 01.11.2026

DOI: 10.1002/pros.70274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Prostate, online erschienen am 01.11.2026. Verfasst von Serafettin Kaymak und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Haymana State Hospital, Ankara, Turkey. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acromegaly is characterized by organomegaly driven by chronic GH/IGF‐1 excess, and the prostate gland may be affected as part of this generalized organ enlargement. Although prostatic enlargement has been documented in previous studies, whether it is accompanied by symptomatic or functional impairment and its potential impact on quality of life remain unclear. This study aimed to evaluate prostate‐related changes in male patients with active and remitting acromegaly compared to healthy controls, and to assess their association with lower urinary tract symptoms, mood, and quality of life.

Methods

This cross‐sectional study included 57 male patients with acromegaly (25 active, 32 in remission) and 24 healthy male controls of comparable age and BMI. All participants underwent transabdominal prostate ultrasonography, uroflowmetry, and completed the IPSS, SF‐36, PHQ‐9, GAD‐7, and FSS questionnaires. The AcroQoL was administered to the acromegaly group. Correlations between IGF‐1 levels and prostate parameters were analyzed using Spearman's correlation.

Results

Patients with acromegaly had a larger median prostate volume (30 vs. 20 mL, p = 0.03), more frequently had a prostate volume exceeding 30 mL (47% vs. 11%, p = 0.004), and more frequently had prostatic calcification (31% vs. 5%, p = 0.03) than controls, despite lower testosterone levels. Within the acromegaly group, a prostate volume exceeding 30 mL was more frequent in active disease than in remission (64% vs. 33%, p = 0.02), whereas median prostate volume did not differ significantly (31 vs. 24.5 mL, p = 0.1). IGF‐1 was correlated with free PSA (rho = 0.29, p = 0.03) but not with total prostate volume (rho = 0.09, p = 0.53). Calcification rates did not differ by remission status. No significant differences were observed in IPSS scores, uroflowmetry parameters, SF‐36, PHQ‐9, GAD‐7, or AcroQoL between groups.

Conclusion

Male patients with acromegaly have larger prostate volumes and more frequent prostatic calcification than controls; prostatic enlargement was more frequent in active disease, whereas calcification did not differ by remission status. These structural alterations were not accompanied by differences in lower urinary tract symptoms, uroflowmetry parameters, or quality of life, suggesting that dedicated urologic surveillance may not be warranted in asymptomatic middle‐aged patients.

Schlagwörter

Stichwörter der Autor:innen

acromegalyinsulin‐like growth factor‐1lower urinary tract symptomsprostateprostate‐specific antigenquality of life

Autor:innen und Institutionen

  • Department of Urology, Haymana State Hospital, Ankara, Turkey.
  • Department of Urology, Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey.
  • Department of Endocrinology and Metabolism, Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey.
  • Department of Internal Medicine, Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey.
  • Department of Radiology, Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey.
  • HATMER (Pituitary Diseases Research and Application Center), University of Health Sciences, Istanbul, Turkey.

ORCID-Profile: Serafettin Kaymak, Halil Lutfi Canat, Aylin Coskun, Esra Hatipoglu

Zitieren

APA

Kaymak, S., Canat, H. L., Coskun, A., Cicek, M. Z., Barut, H. Y., Niyazoglu, M., & Hatipoglu, E. (2026). Prostatic Enlargement in Acromegaly Despite Preserved Lower Urinary Tract Function: A Cross‐Sectional Comparative Study. The Prostate. https://doi.org/10.1002/pros.70274

Vancouver

Kaymak S, Canat HL, Coskun A, Cicek MZ, Barut HY, Niyazoglu M, et al. Prostatic Enlargement in Acromegaly Despite Preserved Lower Urinary Tract Function: A Cross‐Sectional Comparative Study. The Prostate. 2026. doi:10.1002/pros.70274

BibTeX
@article{Kaymak2026,
  author = {Kaymak, Serafettin and Canat, Halil Lutfi and Coskun, Aylin and Cicek, Muhammed Zeki and Barut, Hamit Yucel and Niyazoglu, Mutlu and Hatipoglu, Esra},
  title = {Prostatic Enlargement in Acromegaly Despite Preserved Lower Urinary Tract Function: A Cross‐Sectional Comparative Study},
  journal = {The Prostate},
  year = {2026},
  doi = {10.1002/pros.70274}
}
Kostenlos starten →